Bank Of America Corp Taysha Gene Therapies, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 123,974 shares of TSHA stock, worth $266,544. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,974
Previous 125,713
1.38%
Holding current value
$266,544
Previous $360,000
23.06%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TSHA
# of Institutions
107Shares Held
136MCall Options Held
65.4KPut Options Held
41.7K-
Rtw Investments, LP New York, NY18.8MShares$40.4 Million0.7% of portfolio
-
Avoro Capital Advisors LLC New York, NY18.7MShares$40.1 Million0.57% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$25.2 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$23.4 Million0.37% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$19.4 Million2.21% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $104M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...